Clinical Trials · NCT04366726

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

Name: Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Abaloparatide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Radius Health, Inc.
Enrollment: 22
Start date: Apr 2019
Locations: 1 site, United States
Primary endpoint: Abaloparatide Maximum Plasma Concentration (Cmax) on Day 29

View Abaloparatide compound reference